Cat.No. |
Chemical Name |
MolFormula |
HR257829 |
Lithium 5-bromo-1-methyl-1H-imidazole-2-carboxylate |
C5H4BrLiN2O2 |
HR257827 |
Lithium 5-chloro-1-methyl-1H-imidazole-2-carboxylate |
C5H4ClLiN2O2 |
HR256685 |
L-Histidine, hydrochloride (1:x) |
C6H10ClN3O2 |
HR256643 |
H-His-NH2.2HCl |
C6H12Cl2N4O |
HR254886 |
Ledipasvir Intermediate |
C47H51F2N7O5 |
HR254761 |
Lithium hydride |
HLi |
HR254760 |
Lithium deuteride |
HLi |
HR254759 |
Lithium aluminum deuteride |
AlH4Li |
HR254736 |
Lithium chloride hydrate |
ClH2LiO |
HR254643 |
L-lysine acetate |
C8H18N2O4 |
HR254466 |
Levothyroxine T4 lactic acid |
|
HR254465 |
Levothyroxine imp F( T6 LTX) |
|
HR254464 |
Levothyroxine imp B (Mono chloro) |
|
HR254462 |
Levothyroxine O- methyl ethyl amine imp |
|
HR253930 |
Loperamide N-Oxide |
|
HR253928 |
Lovastatin Impurity B |
|
HR253927 |
Lidocaine Impurity-K (free base) |
|
HR253925 |
Linezolid Chlorohydrin Impurity |
|
HR253923 |
Linezolid Desacetamide Descarbonyl |
|
HR253922 |
Linezolid Desacetamide Descarbonyl Phthalimide |
|
HR253921 |
Linezolid Inhouse impurity |
|
HR253919 |
Linezolid Impurity 21 |
|
HR253917 |
Linagliptin Impurity 68 |
|
HR253915 |
Linagliptin Impurity 22 |
|
HR253914 |
Linagliptin Impurity 20 |
|
HR253912 |
Linagliptin Impurity 14 |
|
HR253864 |
Efavirenz Racemic mixture |
|
HR253722 |
LEAD SULPHATE |
O4PbS |
HR253721 |
LEAD OXIDE YELLOW |
|
HR253497 |
Lurasidone |
|